Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. AMD
6. GOOG
7. INTC
8. CSX
9. IBM
10. KNX

Go back to Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
(NASDAQ: PSTV) Delayed: 3.78 -0.04 (1.05%)
Previous Close $3.82    52 Week High $ 
Open $3.77    52 Week Low $ 
Day High $3.89    P/E N/A 
Day Low $3.72    EPS $ 
Volume 63,802